<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04261504</url>
  </required_header>
  <id_info>
    <org_study_id>IRB2018-943</org_study_id>
    <nct_id>NCT04261504</nct_id>
  </id_info>
  <brief_title>Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention</brief_title>
  <official_title>Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will examine brain mechanisms of a brief mindfulness intervention - IBMT
      on ATC reduction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The R61 phase of the proposed study will examine brain mechanisms of a brief mindfulness
      intervention - IBMT that targets at self-control networks in the brain, and test IBMT effects
      on ATC reduction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain changes of IBMT on polysubstance use</measure>
    <time_frame>The outcome measures are assessed at baseline, 2-4 weeks and 3 months</time_frame>
    <description>70 participants with polysubstance use are assessed by changes of behavior (NIH PhenX Toolkit, RDoC matrix) and brain (fMRI) before (baseline) and after interventions (2-4 Weeks) and 3 months of follow-ups.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Multiple Drug Use</condition>
  <arm_group>
    <arm_group_label>Integrative Body Mind Training (IBMT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mindfulness</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Relaxation Training (RT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>relaxation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IBMT</intervention_name>
    <description>mindful presence in a non-judgmental way</description>
    <arm_group_label>Integrative Body Mind Training (IBMT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>RT</intervention_name>
    <description>progressive muscle relaxation</description>
    <arm_group_label>Relaxation Training (RT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) at least 18 years old;

          -  (2) free of any psychiatric diagnoses or medication (besides a SUD to alcohol,
             tobacco, or cannabis);

          -  (3) in the past month, at least 4 episode of heavy episodic drinking; at least 3
             occasion of cannabis use; and daily cigarette use for at least the past month;

          -  (4) normal or corrected-to-normal vision;

          -  (5) written informed consent;

          -  (6) no previous meditation or NF experiences.

        Exclusion Criteria:

          -  (1) any psychiatric diagnoses other than an SUD;

          -  (2) medical disorder(s) that may affect the central nervous system; medications that
             affect the central and autonomic nervous system; or a positive pregnancy test result
             (females);

          -  (3) excluding cannabis, evidence of recent (past month) illicit drug use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>23 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi-Yuan Tang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi-Yuan Tang</last_name>
    <phone>5419683281</phone>
    <email>yiyuan.tang@ttu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>TTU/UT</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi-Yuan Tang</last_name>
      <phone>541-968-3281</phone>
      <email>yiyuan.tang@ttu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 22, 2019</study_first_submitted>
  <study_first_submitted_qc>February 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

